USD 0.2
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 237.33 Million | 71.7 Million | 54.16 Million | 71.7 Million | 15.4 Million | 10.4 Million |
Net Income | -91.43 Million | -35.32 Million | -15.41 Million | -35.32 Million | -2.48 Million | 3.94 Million |
Depreciation & Amortization | 264.07 Million | 55.98 Million | 52.66 Million | 55.98 Million | 13.09 Million | 6.12 Million |
Deferred income taxes | - | 11.79 Million | -33 Thousand | 11.79 Million | 6064.46 | -8762.15 |
Stock-based compensation | 321.68 Thousand | 93 Thousand | 169 Thousand | 93 Thousand | 440 Thousand | 762 Thousand |
Change in working capital | 85.14 Million | 5.85 Million | -12.34 Million | 5.85 Million | -2.8 Million | -2.4 Million |
Other non-cash items | -20.76 Million | 33.02 Million | 29.12 Million | 33.02 Million | 7.45 Million | 2.53 Million |
Investing Cash Flow | -203.52 Million | -15.52 Million | 30.2 Million | -15.52 Million | 3.11 Million | 7.64 Million |
Investments in PPE | -1.28 Million | -387 Thousand | -491 Thousand | -387 Thousand | -6.9 Million | -10.75 Million |
Acquisitions | - | 509 Thousand | 235 Thousand | 509 Thousand | 228.71 Thousand | - |
Investment purchases | - | -86.17 Million | -9.19 Million | -86.17 Million | -10.84 Million | - |
Sales/Maturities of investments | - | 71.97 Million | 41.09 Million | 71.97 Million | 3.27 Million | 5.84 Million |
Other Investing Activities | -202.24 Million | -1.44 Million | -1.44 Million | -1.44 Million | 17.37 Million | 12.56 Million |
Financing Cash Flow | -36.27 Million | -88.35 Million | -71.71 Million | -88.35 Million | -12.43 Million | -10.35 Million |
Debt repayment | -56.56 Million | -41.94 Million | -47.11 Million | -41.94 Million | -21.89 Million | -7.37 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | 8.29 Million | - | - | 2.85 Million | 232.59 Thousand |
Other Financing Activities | 20.29 Million | -46.41 Million | -24.59 Million | -46.41 Million | 6.59 Million | -3.21 Million |
Accounts receivables | 20.07 Million | -12.51 Million | -9.74 Million | 18.8 Million | 6.57 Million | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | 65.06 Million | 8.67 Million | -4.04 Million | 33.52 Million | -10.45 Million | - |
Cash at beginning of period | 164.33 Million | 104.41 Million | 75.58 Million | 104.41 Million | 23.19 Million | 14.24 Million |
Cash at end of period | 161.62 Million | 75.58 Million | 90.2 Million | 75.58 Million | 30.15 Million | 21.32 Million |
Capital Expenditure | -1.28 Million | -387 Thousand | -491 Thousand | -387 Thousand | -6.9 Million | -10.75 Million |
Effect of forex changes on cash | -4.83 Million | 3.33 Million | 1.95 Million | 3.33 Million | 872.7 Thousand | -608.83 Thousand |
Net cash flow / Change in cash | -2.71 Million | -28.83 Million | 14.61 Million | -28.83 Million | 6.96 Million | 7.08 Million |
Free Cash Flow | 236.05 Million | 71.32 Million | 53.67 Million | 71.32 Million | 8.5 Million | -356.06 Thousand |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -900.21 Thousand | 697.69 Thousand | -91.43 Million | -65.7 Million | -2.72 Million | -2.56 Million |
Depreciation & Amortization | 12.9 Million | 13.02 Million | 264.07 Million | 121.9 Million | 13.13 Million | 13.11 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | 4000.00 | 11 Thousand | 321.68 Thousand | 50.6 Thousand | 14 Thousand | 30 Thousand |
Change in working capital | -4 Million | 10.47 Million | 85.14 Million | -1.27 Million | -842 Thousand | -329 Thousand |
Other non-cash items | 34.45 Million | 17.26 Million | -20.76 Million | -16.49 Million | 1.48 Million | 1.64 Million |
Investing Cash Flow | -470.31 Thousand | -457.86 Thousand | -203.52 Million | -30.55 Million | -9.25 Million | -10.23 Million |
Investments in PPE | -40.93 Thousand | -100.09 Thousand | -1.28 Million | 3.55 Million | -464 Thousand | -530 Thousand |
Acquisitions | - | - | - | - | -155 Thousand | - |
Investment purchases | -74.32 Thousand | - | - | - | -147.06 Thousand | -360 Thousand |
Sales/Maturities of investments | - | - | - | - | 147.06 Thousand | - |
Other Investing Activities | -355.05 Thousand | -357.76 Thousand | -202.24 Million | -34.11 Million | -8.63 Million | -9.34 Million |
Financing Cash Flow | -3.6 Million | -4.61 Million | -36.27 Million | -13.27 Million | -3.64 Million | -3.65 Million |
Debt repayment | - | - | -56.56 Million | -13.27 Million | -13.91 Million | -13.53 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | 47.03 Thousand | 88.68 Thousand |
Other Financing Activities | -3.6 Million | - | 20.29 Million | - | -3.69 Million | -3.73 Million |
Accounts receivables | -7.1 Million | 8.57 Million | 20.07 Million | -20.86 Million | -1.88 Million | -2.28 Million |
Accounts payables | 496.97 Thousand | 1.3 Million | - | - | -1.03 Million | 104.46 Thousand |
Inventory | - | - | - | - | -198.29 Thousand | -308.63 Thousand |
Other working capital | 2.59 Million | 597.6 Thousand | 65.06 Million | 19.58 Million | 2.27 Million | 2.16 Million |
Cash at beginning of period | 134.92 Million | 103.56 Million | 164.33 Million | 170.22 Million | 47.5 Million | 50.35 Million |
Cash at end of period | 140.15 Million | 134.92 Million | 161.62 Million | 161.62 Million | 44.62 Million | 47.5 Million |
Capital Expenditure | -40.93 Thousand | -100.09 Thousand | -1.28 Million | 3.55 Million | -464 Thousand | -530 Thousand |
Effect of forex changes on cash | -623 Thousand | -495 Thousand | -4.83 Million | 5.68 Million | -1.04 Million | -858 Thousand |
Net cash flow / Change in cash | 5.22 Million | 31.36 Million | -2.71 Million | -8.6 Million | -2.87 Million | -2.85 Million |
Free Cash Flow | 9.99 Million | 25.17 Million | 236.05 Million | 42.02 Million | 10.6 Million | 11.36 Million |
JSCPY
2221
300341
MEDICAB
1419
0LB2